Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.

[1]  D. Dewailly,et al.  The numbers of 2– 5 and 6–9 mm ovarian follicles are inversely correlated in both normal women and in polycystic ovary syndrome patients: what is the missing link? , 2018, Human reproduction.

[2]  T. Piltonen,et al.  Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood , 2018, Nature Medicine.

[3]  M. Mansournia,et al.  Prediction of age at menopause in women with polycystic ovary syndrome , 2018, Climacteric : the journal of the International Menopause Society.

[4]  R. Fanchin,et al.  Dysregulation of the Anti‐Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome , 2017, The Journal of clinical endocrinology and metabolism.

[5]  D. Dewailly,et al.  Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome , 2017, Human reproduction.

[6]  M. Urbanek,et al.  Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome , 2017, The Journal of clinical endocrinology and metabolism.

[7]  J. Bergquist,et al.  Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain , 2017, European journal of endocrinology.

[8]  M. Maliqueo,et al.  Obesity during pregnancy affects sex steroid concentrations depending on fetal gender , 2017, International Journal of Obesity.

[9]  C. Venetis,et al.  Anti-Müllerian hormone kinetics in pregnancy and post-partum: a systematic review. , 2017, Reproductive biomedicine online.

[10]  T. Iwasa,et al.  Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome. , 2017, Endocrine journal.

[11]  N. Calder,et al.  Anti‐Müllerian hormone reflects the severity of polycystic ovary syndrome , 2017, Clinical endocrinology.

[12]  E. Karabulut,et al.  The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. , 2016, Human reproduction.

[13]  A. Messina,et al.  Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion , 2016, Nature Communications.

[14]  A. Skalkidou,et al.  Corticotropin-releasing hormone and postpartum depression: A longitudinal study , 2015, Psychoneuroendocrinology.

[15]  F. Petraglia,et al.  Placenta expresses anti-Müllerian hormone and its receptor: Sex-related difference in fetal membranes. , 2015, Placenta.

[16]  F. Petraglia,et al.  Increased expression of antimüllerian hormone and its receptor in endometriosis. , 2014, Fertility and sterility.

[17]  N. Raine-Fenning,et al.  Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. , 2013, Molecular human reproduction.

[18]  C. Lambalk,et al.  Reproductive hormone concentrations in pregnancy and neonates: a systematic review. , 2013, Reproductive biomedicine online.

[19]  S. Iliodromiti,et al.  Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. , 2013, The Journal of clinical endocrinology and metabolism.

[20]  R. Fanchin,et al.  Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. , 2013, Human reproduction.

[21]  T. Sir-Petermann,et al.  Placental steroidogenesis in pregnant women with polycystic ovary syndrome. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[22]  J. Visser,et al.  Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency , 2012, Nature Reviews Endocrinology.

[23]  J. Preisler,et al.  Relationship Between Anti-Müllerian Hormone (AMH) and Insulin Levels During Different Tanner Stages in Daughters of Women With Polycystic Ovary Syndrome , 2012, Reproductive Sciences.

[24]  M. Santillan,et al.  The influence of fetal sex on patterns of change in anti-Mullerian hormone during pregnancy , 2012 .

[25]  S. Carlsen,et al.  Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns. , 2012, Fertility and sterility.

[26]  A. Duhamel,et al.  Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. , 2011, Human reproduction.

[27]  L. Dunkel,et al.  Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. , 2011, The Journal of clinical endocrinology and metabolism.

[28]  S. Rice,et al.  Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high? , 2010, Reproduction.

[29]  R. Norman,et al.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.

[30]  I. Katsikis,et al.  Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. , 2009, American journal of physiology. Endocrinology and metabolism.

[31]  A. Uitterlinden,et al.  A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. , 2008, The Journal of clinical endocrinology and metabolism.

[32]  E. Stener-Victorin,et al.  A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. , 2007, Endocrinology.

[33]  D. Boomsma,et al.  0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(6):2100–2104 Printed in U.S.A. Copyright © 2006 by The Endocrine Society doi: 10.1210/jc.2005-1494 Heritability of Polycystic Ovary Syndrome in a Dutch Twin-Family Study , 2022 .

[34]  D. Abbott,et al.  Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? , 2005, Human reproduction update.

[35]  A. Ruokonen,et al.  Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. , 2005, Human reproduction.

[36]  V. de Leo,et al.  Anti-Müllerian hormone concentrations in maternal serum during pregnancy. , 2005, Human reproduction.

[37]  P. Claman.  Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[38]  B. Fauser,et al.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. , 2004, Molecular human reproduction.

[39]  D. Dewailly,et al.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. , 2003, The Journal of clinical endocrinology and metabolism.

[40]  F. Broekmans,et al.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. , 2002, Human reproduction.

[41]  M. Matzuk,et al.  Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. , 2001, Endocrinology.

[42]  A. Durlinger,et al.  Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1. , 1999, Endocrinology.

[43]  A. Rockwood,et al.  Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome. , 2016, European journal of endocrinology.

[44]  J. Preisler,et al.  Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters. , 2012, Fertility and sterility.

[45]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[46]  Y. Siow,et al.  Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. , 2002, Fertility and sterility.